Core Biogenesis raised €10M in a Series A round in Jul 2022. The company is based in Strasbourg, France. Investors in the round: Blue Horizon Ventures, Thia Ventures, XAnge. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
